New treatment target verification for myelodysplastic syndrome
A research group from Kumamoto University, Japan, analyzed the pathophysiology of myelodysplastic syndrome (MDS), a blood cancer that presents often in the elderly, and found the presence of the transcription factor RUNX3, ...
Jun 9, 2020
0
0